Boston Scientific CEO says Congress should repeal device excise tax

07/5/2011 | Star Tribune (Minneapolis-St. Paul, Minn.)

Congress should work to rescind the 2.3% excise tax on medical devices in the health care law because it will stifle innovation and job growth, Boston Scientific President and CEO Ray Elliott writes in this Star Tribune opinion. Repealing the tax "would help protect the 2 million Americans whose jobs are supported by the medical technology sector and remove burdens on a uniquely American industry that collectively spends more than $10 billion annually on R&D, boasts a net trade surplus and has historically led the world in developing leading-edge medical technologies," Elliott writes.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations